| Financial Year |
September 30 2022 |
| Monetary Funds |
183,361,781.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
2,179,573,760.87 |
| Advances to Suppliers |
198,691,497.14 |
| Other Receivables |
129,184,865.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
993,193.50 |
| Dividend Receivable |
-- |
| Inventories |
4,064,979,365.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
13,883,376.39 |
| Other Current Assets |
318,741,044.29 |
| Total Current Assets |
7,088,415,691.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
132,913,642.47 |
| Investment Properties |
4,977,980.40 |
| Fixed Assetes |
346,149,919.04 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,278,789.54 |
| R&D expenses |
-- |
| Goodwill |
192,600,256.80 |
| Long-Term Deferred and Prepaid Expenses |
8,499,293.35 |
| Deferred Income Tax Assets |
717,664,537.81 |
| Other Non-Current Assets |
194,699.62 |
| Sub-Total of Non-Current Assets |
1,532,014,527.09 |
| Total Assets |
8,620,430,218.43 |
| Short-Term Loans |
5,675,183,382.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,000,000.00 |
| Accounts Payable |
271,739,016.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,953,060.81 |
| Taxes Payable |
42,493,901.69 |
| Interest Payable |
263,819,393.48 |
| Dividend Payable |
235,000.00 |
| Other payables |
310,835,912.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
251,557,407.28 |
| Other Current Liabilities |
80,873,593.86 |
| Sub-Total of Current Liabilities |
7,280,740,843.14 |
| Long-term Loans |
719,951,944.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
100,002,001.60 |
| Deferred Income Tax Liabilities |
27,890,102.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
896,120,766.60 |
| Total Liabilities |
8,176,861,609.74 |
| Paid-In Capital(Or Share Stock) |
959,925,877.00 |
| Capital Surplus |
3,287,593,761.70 |
| Surplus Reserve |
15,437,870.40 |
| LESS:Treasury Stock |
10,147,800.00 |
| Undistributed Profits |
-3,591,474,269.47 |
| Minority Stockholder's Interest |
-229,899,096.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
673,467,704.98 |
| Owner's Equity（Stockholder's Equity） |
443,568,608.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,620,430,218.43 |
